ICU Medical, Inc. Profile Avatar - Palmy Investing

ICU Medical, Inc.

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroCla…

Medical - Instruments & Supplies
US, San Clemente [HQ]

Ratios

15 Records · Starting from 2009
Margins, Growth Rates In %
Ratio 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Profitability
Gross Margin
47.00 45.89 47.11 49.39 49.32 48.96 52.92 53.09 32.96 40.72 37.27 36.31 37.34 30.60 31.42
Profit Margin
11.47 10.87 14.78 13.03 12.88 8.52 13.17 16.63 5.31 2.06 7.98 6.83 7.84 -3.26 -1.31
Operating Margin
16.40 17.32 21.58 19.34 16.56 12.62 20.07 21.86 -1.17 1.54 4.99 3.29 3.98 -0.38 1.76
EPS Growth
4.65 22.22 46.82 -10.22 -5.17 -37.46 65.12 37.32 -10.26 -62.00 268.42 -15.10 16.83 -163.99 60.45
Return on Assets (ROA)
8.59 9.91 12.28 9.63 8.09 4.87 7.18 8.95 4.59 1.82 5.97 4.93 5.48 -1.65 -0.68
Return on Equity (ROE)
10.02 11.28 13.82 10.56 8.70 5.18 7.76 9.56 5.73 2.28 7.34 5.78 6.38 -3.55 -1.40
Return on Invested Capital (ROIC)
9.72 11.25 13.57 10.47 8.57 5.08 7.63 9.31 -1.66 2.21 3.94 2.40 2.64 -0.15 0.40
Solvency
Equity Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt/Assets
- - - - - - - - - - - - - - - - 1.05 -0.29 2.14 2.96 2.40 36.61 37.68
Debt/Equity
- - - - - - - - - - - - - - - - 1.32 -0.36 2.63 3.47 2.79 79.11 77.70
Debt/EBITDA
-97.69 -118.58 -203.95 -182.99 -316.31 -401.65 -296.86 -335.44 -424.04 -181.00 -156.58 -251.69 -357.39 637.93 499.53
Debt/Capitalization
- - - - - - - - - - - - - - - - 1.30 -0.37 2.57 3.35 2.71 44.17 43.72
Interest Debt per Share USD
- - - - - - - - - - - - - - - - 0.91 -0.18 1.78 2.58 2.16 72.05 74.10
Debt Growth
- - - - - - - - - - - - - - - - - - - - - - 43.82 -13.62 3,570.31 3.11
Liquidity
Current Ratio
617.10 806.74 897.27 1,117.88 1,466.55 1,521.90 1,184.96 1,403.90 411.17 371.87 355.05 471.01 512.91 249.76 253.11
Quick Ratio
462.70 576.29 708.70 945.42 1,272.81 1,342.99 1,021.27 2,334.47 247.15 232.08 199.16 273.61 335.27 87.90 86.97
Cash Ratio
152.09 306.07 339.78 504.50 840.67 960.08 788.78 1,097.96 137.94 138.31 108.13 202.62 275.34 42.22 52.76
Operating Cash Flow Ratio
100 100 200 200 200 200 100 200 - - - - - - 100 100 - - - -
Turnover
Inventory Turnover
296.89 349.53 395.42 441.36 461.48 427.42 368.70 361.27 300.19 266.75 235.26 257.05 284.19 227.33 218.37
Receivables Turnover
484.57 516.43 633.06 645.00 692.26 791.94 590.64 675.51 588.62 712.72 626.16 1,024.24 1,243.04 1,028.33 1,374.70
Payables Turnover
665.99 1,415.47 1,206.26 1,418.10 1,402.59 1,387.41 1,176.82 1,215.59 1,107.68 688.98 617.55 1,126.44 1,016.69 732.85 1,032.47
Asset Turnover
74.89 91.15 83.09 73.95 62.79 57.15 54.51 53.84 86.35 88.31 74.82 72.07 69.99 50.49 51.59
Coverage
Interest Coverage
- - - - - - - - - - - - - - - - -736.59 3,048.24 11,515.48 2,385.00 6,105.24 -13.11 29.33
Asset Coverage
- - - - - - - - - - - - - - - - - - - - 3,400 2,600 3,300 100 100
Cash Flow Coverage (CFGR)
- - - - - - - - - - - - - - - - 979.97 -3,482.93 281.09 427.16 593.91 -3.76 10.07
EBITDA Coverage
- - - - - - - - - - - - - - - - 3,300 26,800 27,000 7,700 16,500 300 200
Dividend Coverage
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Time Interest Earned (TIE)
100 100 100 100 100 100 100 100 100 100 100 100 100 - - 100
Market Prospects
Dividend Yield
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Earnings Yield
4.95 6.23 7.18 4.76 4.32 2.10 2.52 2.65 1.62 0.58 2.62 1.94 2.05 -1.98 -1.23
Price/Earnings (P/E)
20.1979 16.0626 13.9375 20.9929 23.1524 47.5259 39.7319 37.7648 61.7188 172.2723 38.2056 51.6213 48.8004 -50.5981 -81.0263
Price/Book (P/B)
202.41 181.13 192.65 221.72 201.36 246.25 308.23 360.88 353.57 392.53 280.28 298.51 311.44 179.85 113.16
Price/Sales (P/S)
231.69 174.57 206.02 273.49 298.29 404.71 523.12 627.97 327.76 354.29 304.86 352.82 382.36 164.86 106.38
Price/Cash Flow (P/CF)
1,103.49 1,501.14 965.43 1,307.67 1,461.69 2,063.98 3,257.70 2,648.80 2,743.52 3,095.99 3,787.46 2,013.15 1,881.24 -6,049.88 1,445.74
End of ICUI's Analysis
CIK: 883984 CUSIP: 44930G107 ISIN: US44930G1076 LEI: - UEI: -
Secondary Listings
ICUI has no secondary listings inside our databases.